Company: TEDA Biological Science and Technology Inc. Tianjin

Total Investment: RMB￥10,000,000

Business Form: Joint Venture

Investment Recovery Time: Three to five (3-5) years

Business Summary: Combined type hemodialyzer is a kind of blood decontamination plant developed by combining the new technology of hemodialysis and blood perfusion. It can eliminate effectively the toxin within the blood of the patient who is at the advanced stage of renal failure. The technology reaches the international advanced level. Parts of the products will be exported,

Contact Address: Business-carving Center, TEDA, Tianjin

Contact Person: Fang Yuhui

Telephone number: 86-22-25329570

Market Forecast: The project technology is matured and reaches or exceeds the international advanced level. As a leading production on domestic market, the extension of the products market will be great. It can not only take the place of imported products, but also export to make profits in foreign currency.

Brief Introduction of Chinese Partner:

Born in 2000, TEDA Biological Science and Technology Co., Ltd. Tianjin is a joint-stock enterprise with a total amount of register capital of RMB￥30,000,000. The main business of the company includes biological medicine project and the research, production, sales and corresponding technological service of biological technology and its relevant products (consisting of biological material and medical care instrument). The company owns a great numbers of well-known specialists and scientific researchers who are experienced and skillful in the fields of biological medicine and materials. In addition, their achievement has been partly turned into greatly competitive products.